Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)
Recruiting now · Not applicable
Conditions studied: Idiopathic Normal Pressure Hydrocephalus
In brief
The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research
Key facts
- Study ID
- NCT04998175
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- People needed
- 40
- Starts
- 2020-09-15
- Expected to finish
- 2026-12-30
- Last updated by the study team
- 2026-04-24
Who can join
Age: 60 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 60 years;
- Diagnosis of iNPH based on clinical assessment
- Participant is able to give written informed consent
You may not qualify if…
- Combining AD and Parkinson's disease and other nervous system diseases
- Participant is not medically available for shunt surgery
- Secondary NPH
Where it is running
- The second affliated hospital of zhejiang university — Hangzhou, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.